Morgan Stanley (NYSE: MS) is a leading global financial services firm active in investment banking, securities, and wealth management, competing with industry giants like Goldman Sachs (NYSE: GS). The company’s total market value, or market capitalization, is approximately $299.85 billion. This figure represents the total worth of all its outstanding shares, a key metric in stock analysis.
A recent filing highlights an insider transaction, showing Co-President Daniel A. Simkowitz selling 14,690 shares of Morgan Stanley on April 17, 2026. The transaction occurred at $189.24 per share, totaling approximately $2.78 million. After this share sale, Simkowitz still holds 365,802 shares, maintaining a significant investment in the financial services giant.
While an insider sells shares, market trends indicate some institutional investors are actively buying. As highlighted by Defense World, Farther Finance Advisors LLC increased its holdings in Morgan Stanley by 40.1%, now owning shares worth over $5.2 million. Additionally, Natural Investments LLC established a new position in the company valued at $221,000, reflecting positive institutional investment sentiment.
This activity comes as Morgan Stanley reports strong financial results. The company announced a 16% year-over-year increase in net revenues to a record $20.6 billion for the first quarter. Earnings per share (EPS) also showed 32% growth, reaching $3.43 per share, indicating robust financial performance in its core businesses and strong Q1 earnings.
Analysts reacted positively to the earnings report and Morgan Stanley's financial performance. As highlighted by Benzinga, RBC Capital called the quarter a "home run." Following these impressive results, Barclays (NYSE: BCS) raised its price target on Morgan Stanley to $230, while Goldman Sachs increased its price target to $205, as noted by 247wallst.com. These analyst upgrades reflect strong market confidence.
